FDA issues Class I recall for Abiomed Impella heart pump controllers.
The U.S. FDA has classified a correction for Johnson & Johnson's Abiomed Impella heart pump controllers as a Class I recall. This indicates a high potential for serious injury or death due to four identified hardware issues. These malfunctions could lead to delays or complete loss of critical hemodynamic support for patients.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.